Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Finland’s Orion for its new Easyhaler combination product for the treatment of asthma and chronic obstructive pulmonary disease. Under the terms of the agreement, Hikma has the exclusive rights to register, distribute, market and sell the product in all of its MENA markets, leveraging the company’s local presence, sales and marketing capabilities and regulatory expertise.